EDAP TMS S.A. (EDAP)
 NASDAQ: EDAP · Real-Time Price · USD
 2.020
 -0.120 (-5.61%)
  At close: Nov 3, 2025, 4:00 PM EST
2.000
 -0.020 (-0.99%)
  After-hours: Nov 3, 2025, 4:16 PM EST
EDAP TMS Market Cap
EDAP TMS has a market cap or net worth of $75.53 million as of November 3, 2025. Its market cap has decreased by -25.66% in one year.
Market Cap 
 75.53M
Enterprise Value 
 75.80M
1-Year Change 
 -25.66%
Ranking 
 Category 
 Stock Price 
$2.02
Market Cap Chart
Since December 31, 2001, EDAP TMS's market cap has increased from $17.50M to $75.53M, an increase of 331.61%. That is a compound annual growth rate of 6.32%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 31, 2025 | 79.60M | -3.28% | 
| Dec 31, 2024 | 82.30M | -57.88% | 
| Dec 29, 2023 | 195.40M | -45.60% | 
| Dec 30, 2022 | 359.20M | 86.11% | 
| Dec 31, 2021 | 193.00M | 28.07% | 
| Dec 31, 2020 | 150.70M | 17.28% | 
| Dec 31, 2019 | 128.50M | 139.74% | 
| Dec 31, 2018 | 53.60M | -34.95% | 
| Dec 29, 2017 | 82.40M | -1.08% | 
| Dec 30, 2016 | 83.30M | -18.89% | 
| Dec 31, 2015 | 102.70M | 102.17% | 
| Dec 31, 2014 | 50.80M | -6.27% | 
| Dec 31, 2013 | 54.20M | 99.26% | 
| Dec 31, 2012 | 27.20M | 23.64% | 
| Dec 30, 2011 | 22.00M | -64.23% | 
| Dec 31, 2010 | 61.50M | 132.95% | 
| Dec 31, 2009 | 26.40M | 100.00% | 
| Dec 31, 2008 | 13.20M | -68.79% | 
| Dec 31, 2007 | 42.30M | -7.44% | 
| Dec 29, 2006 | 45.70M | 4.10% | 
| Dec 30, 2005 | 43.90M | 48.31% | 
| Dec 31, 2004 | 29.60M | 112.95% | 
| Dec 31, 2003 | 13.90M | 49.46% | 
| Dec 31, 2002 | 9.30M | -46.86% | 
| Dec 31, 2001 | 17.50M | - | 
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 772.59B | 
| Johnson & Johnson | 455.04B | 
| AbbVie | 385.18B | 
| UnitedHealth Group | 309.40B | 
| AstraZeneca | 253.98B | 
| Novartis AG | 237.13B | 
| Novo Nordisk | 216.87B | 
| Abbott Laboratories | 214.96B |